TMPRSS2 and COVID-19: It has been suggested that another TMPRSS2 inhibitor, bromhexine, presently used as a mucolytic cough suppressant, could be used to treat COVID-19 (Habtemariam et al., 2020; Maggio and Corsini, 2020).